Pharmafile Logo
Pharmafocus logo
Advanced Search

Johnson & Johnson

Showing 15 posts of 147 posts found.

J&J and Vertex’s hep C drug Incivek approved by FDA

May 24, 2011
Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir

The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …

News

HIV drug Prezista recalled on TBA contamination

May 17, 2011
Manufacturing and Production HIV, Johnson & Johnson, Prezista, manufacturing and production, recalls

Johnson & Johnson has recalled 11,700 bottles of its HIV treatment Prezista after consumer reports of a mouldy smell caused …

News

Prostate cancer drug Zytiga gains US approval

May 5, 2011
Sales and Marketing Centocor Ortho Biotech, Johnson & Johnson, Zytiga, prostate cancer

Zytiga a new treatment for the most hard to treat cases of prostate cancer has been approved in the US. …

News
William Weldon

Top 5 reasons for a Class I product recall

April 21, 2011
Manufacturing and Production Johnson & Johnson, product recalls

Having to recall a pharmaceutical product because of a major quality defect or safety issue is a heart sinking moment …

Feature
Arthritis drug Remicade

J&J and Merck reach compromise on arthritis drug rights

April 19, 2011
Sales and Marketing Johnson & Johnson, Merck & Co, Remicade, Simponi

Johnson & Johnson and Merck & Co have agreed to split the regional rights to arthritis drugs Remicade and Simponi …

News
Johnson & Johnson's Tylenol

J&J reorganises McNeil as recalls keep coming

April 5, 2011
Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, TBA, TCA, Tylenol, manufacturing compliance, pharma manufacturing, recalls, tribromoanisole, trichloroanisole

Johnson & Johnson has announced a major reworking of its troubled McNeil Consumer Healthcare unit, just as quality problems force …

News

J&J hit by another string of product recalls

February 21, 2011
Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls

There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …

News
Pfizer's Les Meningo – Smash Pursuit iPhone app

Digital Pharma: Pfizer, J&J and Merck withdraw iPhone apps

January 7, 2011
Medical Communications Android, Blackberry, Digital Pharma blog, Johnson & Johnson, Merck, Pfizer, apps, ipad, iphone

Big pharma companies have pulled a number of apps from the iTunes store, but it’s not a sign the industry …

News

Congressman says FDA should scrutinise J&J’s manufacturing partners

December 21, 2010
Manufacturing and Production BestSweet, FDA, J&J, JJ, Johnson & Johnson, McNeil, Rolaids, manufacturing compliance, recalls

The latest flurry of recalls from Johnson & Johnson has prompted additional calls for a wide-ranging investigation of the company’s …

News

Race on to find new Johnson & Johnson leader

December 16, 2010
Sales and Marketing Johnson & Johnson, recruitment

Johnson & Johnson is promoting two of its most senior executives as it prepares to replace William Weldon, its current …

News

Millions more OTC products recalled by J&J

November 29, 2010
Manufacturing and Production Benadryl Allergy Fastmelt, J&J, JJ, Johnson & Johnson, Motrin, Rolaids, Tylenol, manufacturing compliance, recalls

Johnson & Johnson has been forced to announce yet another recall of over-the-counter medicines manufactured at its Fort Washington facility …

News

J&J and Takeda issue recall for cancer drug Velcade

November 22, 2010
Manufacturing and Production J&J, JJ, Johnson & Johnson, Takeda Pharmaceuticals, Velcade, bortezomib, pharma manufacturing, product recalls

Johnson & Johnson has been affected by another product recall, on this occasion concerning the cancer drug Velcade (bortezomib) sold …

News

Pharma engages HTA bodies in early-stage drug discussions

October 27, 2010
Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, EMA, European Medicines Agency, GlaxoSmithKline, Johnson & Johnson, health technology assessment, hta

Three pharma companies are taking part in a new pilot to harmonise European standards in health technology assessment (HTA). AstraZeneca, …

News
Johnson & Johnson Tylenol

Johnson & Johnson recalls more Tylenol

October 21, 2010
Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, Tylenol, pharma recalls, product recalls

Johnson & Johnson’s McNeil Consumer Healthcare unit has announced yet another recall affecting its Tylenol painkiller range. The latest recall …

News

Cutting-edge cancer treatments showcased at ESMO

October 18, 2010
Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine

The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025